leisure time -WSS

leisure time

author：hotspot 2025-09-27 12:58:43 - browse：12879

James Fanale, the former CEO and president of Care New England, and his wife Deb (left) on their front porch. -- health coverage from STAT — Courtesy Ryan Pickering

PROVIDENCE – In late August, Dr. James E. Fanale was trudging through the Falmouth Road Race — walking up the hills, running down them — for seven miles. Fellow runners encouraged him to “keep trying” whenever he slowed down. But they couldn’t have known — along with most of the people in Fanale’s professional orbit — that he was battling Stage 4 lung cancer.

“Many times, I wanted to say ‘Listen buddy, you don’t know what I’ve got in me,’” Fanale recalled recently with a chuckle.

In December 2022, on the day Fanale retired as president and CEO of Care New England, he shared his diagnosis with a Globe reporter but requested it be kept private. He was handing the reins to new CEO Dr. Michael Wagner after six years leading the second largest health care system in Rhode Island.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： House panel takes first step toward fixing drug shortages

hotspot

WSS

Albert Bourla of Pfizer: worst biopharma CEO of 2023

Why health records don't always know when patients are dead

HCA sued by state AG for quality issues at Mission Health

The unintended consequences of overturning Roe v. Wade

Medicare Advantage beneficiaries sue Humana over algorithm use

How to keep neuroscience’s past racism from being its future

entertainment

leisure time

hotspot

Malaria cases in Florida and Texas: Here’s what you need to know

SNAP should offer more nutrition education

Medicare proposal to cover medical devices draws a mixed reaction

David Liu startup to focus on CRISPR delivery

BioMarin wins approval for gene therapy to treat hemophilia A

Grail spinoff by Illumina should end disastrous merger attempt

Medical leaders decry Supreme Court decision on affirmative action

Drinking less cuts risk of oral cavity, esophageal cancer: Report

How one medical school became remarkably diverse

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

focus

Covid’s new normal has set in amid another rise in cases

The struggle to figure out which patients 'deserve' Wegovy

Fed up with FDA, ALS advocates consider a take

Albert Bourla of Pfizer: worst biopharma CEO of 2023

SEC charges former device maker CEO with $41 million fraud

Why the drug industry's warnings on the IRA's impact fall short

hotspot

Wikipedia

focus

focus